Dentsply Sirona Announces Appointment of Jorge M. Gomez as Chief Financial Officer
July 08 2019 - 8:15AM
DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental
Solutions Company, today announced the appointment of Jorge M.
Gomez as Chief Financial Officer.
Jorge M. Gomez served as Chief Financial Officer
of Cardinal Health since January 2018, where he was responsible for
financial activities across the enterprise, including financial
strategy, capital deployment, treasury, investor relations, tax,
accounting and external reporting. Prior to that, Jorge was
Chief Financial Officer of the Medical and Pharmaceutical segments,
and Treasurer and Corporate Controller at Cardinal Health.
Before joining Cardinal Health, Jorge held multiple executive and
leadership roles at General Motors and the Smurfit-Kappa Group.
"On behalf of the entire management team, I
would like to extend a warm welcome to Jorge Gomez. He is a
talented global executive with an in-depth knowledge of the
healthcare market, who brings the right mix of skills and
experience, and a solid track record of successfully managing
global finance operations,” said Don Casey, Dentsply Sirona’s CEO.
“In addition, Jorge has a strong business sense and the ability to
collaboratively lead an organization to drive increased shareholder
value. I would also like to thank Nick Alexos for his efforts and
dedication to Dentsply Sirona, and his leadership during the CFO
transition,” continued Mr. Casey.
About Dentsply SironaDentsply
Sirona is the world’s largest manufacturer of professional dental
products and technologies, with a 132-year history of innovation
and service to the dental industry and patients worldwide.
Dentsply Sirona develops, manufactures, and markets a comprehensive
solutions offering including dental and oral health products as
well as other consumable medical devices under a strong portfolio
of world class brands. As The Dental Solutions Company,
Dentsply Sirona’s products provide innovative, high-quality and
effective solutions to advance patient care and deliver better,
safer and faster dentistry. The Company’s shares of common
stock are listed in the United States on Nasdaq under the symbol
XRAY. Visit www.dentsplysirona.com for more information about
Dentsply Sirona and its products.
Contact Information:
Investors:John Sweeney, CFA, IRCVice President,
Investor
Relations+1-717-849-7863John.Sweeney@dentsplysirona.com
Forward-Looking Statements and
Associated Risks
Information the Company has included or
incorporated by reference in filings with the U. S. Securities and
Exchange Commission (the “SEC”) as well as press releases or other
public statements, contains or may contain forward-looking
statements. These forward-looking statements include, among
other things, statements about the Company’s plans, objectives,
expectations (financial or otherwise) or intentions.
The Company’s forward-looking statements involve
risks and uncertainties. Actual results may differ
significantly from those projected or suggested in any
forward-looking statements. The Company does not undertake
any obligation to release publicly any revisions to such
forward-looking statements to reflect events or circumstances
occurring after the date hereof or to reflect the occurrence of
unanticipated events. Any number of factors could cause the
Company’s actual results to differ materially from those
contemplated by any forward-looking statements, including, but not
limited to, the risks associated with the following:
- the Company's ability to successfully implement its cost
reduction and restructuring plans
- the Company’s ability to remain profitable in a very
competitive marketplace, which depends upon the Company’s ability
to differentiate its products and services from those of
competitors
- the Company’s failure to anticipate and appropriately adapt to
changes or trends within the rapidly changing dental
industry
- the effect of changes in the Company’s management and
personnel
- changes in applicable laws, rules or regulations, or their
interpretation or enforcement, or the enactment of new laws, rules
or regulations, which apply to the Company’s business practices
(past, present or future) or require the Company to spend
significant resources for compliance
- a significant failure or disruption in service within the
Company’s operations or the operations of key
distributors
- results in pending and future litigation, investigations or
other proceedings which could subject the Company to significant
monetary damages or penalties and/or require us to change our
business practices, or the costs incurred in connection with such
proceedings
- the Company’s failure to attract and retain talented employees,
or to manage succession and retention for its key
executives
- the Company’s failure to successfully integrate the business
operations or achieve the anticipated benefits from any acquired
businesses
- the Company’s failure to execute on, or other issues arising
under, certain key client contracts
- the impact of the Company’s debt service obligations on the
availability of funds for other business purposes, the terms of and
required compliance with covenants relating to the Company’s
indebtedness and its access to the credit markets in
general
- general economic conditions
- other risks described from time to time in the Company’s
filings with the SEC
You should carefully consider these and other
relevant factors, including those risk factors in Part I, Item 1A,
“Risk Factors” of the Form 10-K and any other information included
or incorporated by reference in the Company’s other filings with
the SEC, when reviewing any forward-looking statement.
Investors should understand it is impossible to predict or identify
all such factors or risks. As such, you should not consider
either foregoing lists, or the risks identified in the Company’s
SEC filings, to be a complete discussion of all potential risks or
uncertainties associated with an investment in the company.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2024 to Apr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Apr 2023 to Apr 2024